Journal of Pharmacogenomics & Pharmacoproteomics

OMICS Publishing Group

Not yet evaluated

About the journal

Journal of Pharmacogenomics & Pharmacoproteomics is a journal published by OMICS Publishing Group. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
OMICS Publishing Group
ISSN
2153-0645
Access
Not open access / not declared

Index listings

  • PUBMED · 2010-10-04
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Dormant — no works recorded since 2021
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

452

Last recorded publication year

2021

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

14

i10-index

25

From OpenAlex open data (CC0).

Editorial & policy2
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity1
Source type
journal
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Genetic Associations and Epidemiology
  • Nutrition, Genetics, and Disease
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Genomics and Rare Diseases
Show all subjects (75)
  • Nutrition, Genetics, and Disease
  • Nutrition, Genetics, and Disease
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer Genomics and Diagnostics
  • Genetics, Bioinformatics, and Biomedical Research
  • Computational Drug Discovery Methods
  • Bioinformatics and Genomic Networks
  • Bioinformatics and Genomic Networks
  • Technology and Human Factors in Education and Health
  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
  • Diet and metabolism studies
  • Diet and metabolism studies
  • MicroRNA in disease regulation
  • Colorectal Cancer Treatments and Studies
  • MicroRNA in disease regulation
  • Artificial Intelligence in Healthcare and Education
  • Colorectal Cancer Treatments and Studies
  • Science, Research, and Medicine
  • Trace Elements in Health
  • Breast Cancer Treatment Studies
  • MicroRNA in disease regulation
  • Metabolomics and Mass Spectrometry Studies
  • Pharmaceutical studies and practices
  • Metabolomics and Mass Spectrometry Studies
  • HIV/AIDS drug development and treatment
  • Pharmaceutical studies and practices
  • Colorectal Cancer Treatments and Studies
  • Biomedical and Engineering Education
  • HIV/AIDS drug development and treatment
  • Drug Transport and Resistance Mechanisms
  • Biomedical and Engineering Education
  • Epigenetics and DNA Methylation
  • Systemic Lupus Erythematosus Research
  • Science, Research, and Medicine
  • Systemic Lupus Erythematosus Research
  • Gene expression and cancer classification
  • Science, Research, and Medicine
  • Gene expression and cancer classification
  • Heavy Metal Exposure and Toxicity
  • Epigenetics and DNA Methylation
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Advanced Biosensing Techniques and Applications
  • Medicinal Plant Research
  • Cancer-related molecular mechanisms research
  • Advanced Biosensing Techniques and Applications
  • Epigenetics and DNA Methylation
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Nanoparticle-Based Drug Delivery
  • Health and Medical Research Impacts
  • Gut microbiota and health
  • Health Systems, Economic Evaluations, Quality of Life
  • Biomedical Text Mining and Ontologies
  • Health Systems, Economic Evaluations, Quality of Life
  • Health and Medical Research Impacts
  • Antioxidant Activity and Oxidative Stress
  • Lipoproteins and Cardiovascular Health
  • Biomedical Text Mining and Ontologies
  • Lipoproteins and Cardiovascular Health
  • Liver Disease Diagnosis and Treatment
  • Lipoproteins and Cardiovascular Health
  • Liver Disease Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: